CD300a:一种天生的免疫检查点,塑造瘤免疫力和治疗机会
1Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
Cancers
|June 13, 2025
概括
CD300a是一种抑制性免疫受体,抑制抗瘤反应并促进免疫逃避. 向CD300a可能通过恢复免疫功能为各种癌症提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子信号传输的方法
背景情况:
- CD300a是免疫球蛋白超级家族中的抑制受体,调节免疫细胞活性.
- 它在髓状和淋巴状细胞上表达,在炎症和瘤免疫力中发挥关键作用.
- CD300a通过招募SHP-1酸酶发出信号,抑制TLR-MyD88和FcεRI等途径.
研究的目的:
- 审查CD300a在瘤免疫中的作用及其作为治疗点的潜力.
- 阐明瘤细胞可能利用CD300a进行免疫逃避的机制.
- 突出CD300a在血液和非血液恶性瘤中的更广泛相关性.
主要方法:
- 在免疫细胞和癌症模型中对CD300a功能研究的文献综述.
- 对瘤微环境中CD300a介导免疫抑制的拟议机制的分析.
- 关于CD300a在各种血液和非血液恶性瘤中的参与的综合证据.
主要成果:
- CD300a抑制免疫反应,包括DC介导的IFN产生,NK细胞细胞毒性和巨细胞/乙酸酶细胞的抗瘤活性.
- 瘤细胞可能会劫持CD300a通路,创造一种免疫抑制环境,促进免疫逃避和瘤存活.
- CD300a在与瘤相关的免疫调节中起到关键的免疫检查点的作用,影响血液恶性瘤和其他癌症.
结论:
- CD300a是一种类免疫调节分子,在癌症免疫学上具有重要意义.
- 它在促进免疫逃避和瘤存活方面的作用将其定位为潜在的治疗标.
- 需要进一步研究CD300a在恶性瘤中的更广泛的相关性和治疗潜力.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861


